1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
China Pharma Holdings, Inc.

China Pharma Holdings, Inc.

CPHI
China Pharma Holdings, Inc.US flagNew York Stock Exchange American
0.86
USD
+0.09
- -
2.73MMarket Cap

Total Valuation

China Pharma Holdings, Inc. carries a market capitalization of 2.73M, placing it among publicly traded companies globally. Its enterprise value stands at 10.34M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.73M
Enterprise Value10.34M

Share Statistics

China Pharma Holdings, Inc. currently has 40.52M shares outstanding.

Shares Outstanding40.52M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 1.67, and the price-to-book ratio stands at -0.14.

PE RatioN/A
PS Ratio1.67
PB Ratio-0.14
P/TBV Ratio-3.24
P/FCF Ratio29.86
P/OCF Ratio39.95

Enterprise Valuation

EV / Sales2.59
EV / EBITDAN/A
EV / EBITN/A
EV / FCF32.03

Financial Position

China Pharma Holdings, Inc. maintains a current ratio of 0.28, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 10.42, indicating elevated leverage, while an interest coverage ratio of -12.16 demonstrates limited ability to service its debt obligations.

Current Ratio0.28
Quick Ratio0.06
Debt / Equity10.42
Debt / EBITDA-3.17
Interest Coverage-12.16

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-11.94
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.13

Stock Price Statistics

China Pharma Holdings, Inc.'s stock has declined approximately -47.25767% over the past 52 weeks. The 50-day moving average sits at 0.68, while the 200-day moving average is 1.20.

Beta (5Y)N/A
52-Week Price Change-47.25767%
50-Day Moving Average0.68
200-Day Moving Average1.20
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, China Pharma Holdings, Inc. generated 3.99M in revenue and converted that into -3.55M in net income, yielding earnings per share of -0.32. EBITDA reached -1.22M, while operating income came in at -3.45M.

Revenue3.99M
Gross Profit289,598.00
Operating Income-3.45M
Pretax Income-3.55M
Net Income-3.55M
EBITDA-1.22M
EBIT-3.45M
Earnings Per Share (EPS)-0.32

Balance Sheet

China Pharma Holdings, Inc. holds 168,474.00 in cash and equivalents against 3.86M in total debt, resulting in a net debt position of 3.52M. Total book value stands at -48.32M, with working capital of -5.26M providing operational flexibility.

Cash & Cash Equivalents168,474.00
Total Debt3.86M
Net Debt3.52M
Equity (Book Value)-48.32M
Book Value Per Share-4.43
Working Capital-5.26M

Cash Flow

China Pharma Holdings, Inc. produced 166,645.00 in operating cash flow over the past twelve months. After subtracting -56,286.00 in capital expenditures, free cash flow totaled 110,359.00 - equivalent to 0.01 per share.

Operating Cash Flow166,645.00
Capital Expenditures-56,286.00
Free Cash Flow110,359.00
FCF Per Share0.01

Margins

China Pharma Holdings, Inc. operates with a gross margin of 7.26, reflecting its pricing power and cost economics. The operating margin of -86.36 and net profit margin of -88.82 provide insight into operational efficiency.

Gross Margin7.26
Operating Margin-86.36
Pretax Margin-88.82
Profit Margin-88.82
EBITDA Margin-30.48

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield4.45
FCF Yield3.35

Stock Splits

China Pharma Holdings, Inc.'s most recent stock split took place on April 15, 2025 with a 10:1 split ratio.

Last Split Date4/15/2025
Split Ratio10:1

Scores

China Pharma Holdings, Inc. posts an Altman Z-Score of -12.94, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-12.94